SphygomoCor® XCEL Pulse Wave Analysis (PWA)
- Clinically validated / FDA Cleared
- Reimbursement CPT code 93050
- Accuracy compared to an intravascular catheter
- Consistently easy to measure in 3 minutes
- Peer reviewed publications across therapeutic areas

SphygmoCor XCEL Pulse Wave Analysis (PWA) System
ATCOR’s noninvasive PWA technology measures a suite of digital vascular biomarkers (right) to personalize patient care and enhance clinical trial endpoint monitoring.
Pulse Wave Analysis (PWA) is an Essential Diagnostic Tool
Central blood pressure and brachial blood pressure are captured. Confirm patient hypertension with both central and brachial blood pressure values. The Oscar™ 2 with SphygmoCor® Inside is complementary to the XCEL, providing a 24-hour assessment of a patient’s day and night central and brachial blood pressure.
The full PWA suite of digital vascular biomarkers are used across multiple therapeutic areas, including but not limited to cardiovascular, oncology, nephrology, neuroscience, sports medicine, women’s health, metabolism, and immunology.


SphygmoCor XCEL PWA Software
The SphygmoCor XCEL PWA software provides clinicians and researchers with a patient’s real-time central aortic pressure waveform. Like a fingerprint, the waveform and suite of digital vascular biomarkers are unique to each patient. The PWA Software includes a personalized patient visit report that is compliant with HIPAA and GDPR regional requirements. Full biomarker data exporting and reporting support are available.